ArticleNature immunology2026
Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy.
Alberto G Conti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it